LVW Advisors LLC Has $514,000 Stock Holdings in Chemed Co. (NYSE:CHE)

LVW Advisors LLC decreased its stake in shares of Chemed Co. (NYSE:CHE) by 6.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 970 shares of the company’s stock after selling 70 shares during the period. LVW Advisors LLC’s holdings in Chemed were worth $514,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Trust Co. of Vermont bought a new stake in shares of Chemed during the fourth quarter worth approximately $34,000. American National Bank & Trust bought a new stake in Chemed in the 3rd quarter valued at $61,000. GAMMA Investing LLC grew its holdings in Chemed by 60.5% in the 3rd quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock valued at $83,000 after buying an additional 52 shares in the last quarter. Quarry LP increased its position in Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock worth $103,000 after buying an additional 166 shares during the period. Finally, Sound Income Strategies LLC bought a new position in Chemed during the 3rd quarter worth $201,000. Institutional investors and hedge funds own 95.85% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on CHE. Royal Bank of Canada decreased their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th.

Chemed Stock Performance

Shares of NYSE CHE opened at $555.01 on Tuesday. The stock has a market capitalization of $8.35 billion, a P/E ratio of 28.04, a PEG ratio of 2.04 and a beta of 0.47. The stock’s fifty day moving average is $545.17 and its 200 day moving average is $562.92. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $654.62.

Chemed (NYSE:CHE) last released its earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. During the same period in the prior year, the business earned $5.32 earnings per share. Chemed’s quarterly revenue was up 7.4% compared to the same quarter last year. Equities research analysts forecast that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date was Monday, November 18th. Chemed’s dividend payout ratio is presently 10.11%.

Insider Activity

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total value of $1,145,540.00. Following the transaction, the chief executive officer now owns 101,735 shares in the company, valued at $58,270,755.95. The trade was a 1.93 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Brian C. Judkins bought 145 shares of the stock in a transaction on Monday, December 30th. The shares were acquired at an average cost of $519.50 per share, with a total value of $75,327.50. Following the purchase, the vice president now owns 1,678 shares of the company’s stock, valued at approximately $871,721. This represents a 9.46 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 3.32% of the company’s stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.